Echogenic vehicle for clinical delivery of plasminogen activator and other fibrin-binding therapeutics to thrombi
US9814672B2 · kind B2 · utility
1Cited by
13References
15Claims
0Family size
Inventors
Key dates
| Filing date | Mar 7, 2008 |
| Grant date | Nov 14, 2017 |
| Priority date | — |
| Expiry date | Dec 6, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P7/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
We disclose a composition comprising an echogenic liposome (ELIP) having an exterior surface, an interior surface, and at least one bilayer comprising at least one lipid selected from the group consisting of saturated phospholipids, unsaturated phospholipids, mixed phospholipids, and cholesterol, and a thrombolytic compound trapped by the ELIP. We also disclose a method of treating a medical condition in a patient characterized by a thrombus in the patient's vasculature, comprising administering to the patient the composition in an amount effective to reduce the size of the thrombus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.